REGN Latest Headlines

Regeneron Pharmaceuticals files automatic mixed securities shelf

at seekingalpha.com (Thu, 31-Oct 4:46 PM)

Why Selling This Iron Condor in REGN Makes Sense for a $22.7 Credit

Market Chameleon (Thu, 31-Oct 4:11 PM)

Eylea headwinds said to be behind Regeneron’s post-Q3 plunge

at seekingalpha.com (Thu, 31-Oct 3:10 PM)

Regeneron Buy Rating: Strong Earnings and Strategic Positioning Amid Market Challenges

at www.tipranks.com (Thu, 31-Oct 1:05 PM)

Regeneron down 10% despite top and bottom line beats

at seekingalpha.com (Thu, 31-Oct 10:40 AM)

Regeneron Pharmaceuticals Non-GAAP EPS of $12.46 beats by $0.75, revenue of $3.72B beats by $50M

at seekingalpha.com (Thu, 31-Oct 6:31 AM)

Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights

at www.benzinga.com (Wed, 30-Oct 3:12 PM)

Regeneron Pharmaceuticals Q3 2024 Earnings Preview

at seekingalpha.com (Wed, 30-Oct 11:14 AM)

Put underwriting and put buying opportunities within the Russell 1000 – JPM

at seekingalpha.com (Wed, 30-Oct 9:58 AM)

EyePoint's Investigational Drug Shows Early And Sustained Improvement Than Regeneron's Eylea For Diabetes-Associated Vision Loss

at www.benzinga.com (Mon, 28-Oct 12:16 PM)

Regeneron (REGN) Gets a Buy from Barclays

at www.tipranks.com (Mon, 28-Oct 5:01 AM)